Skip to main content
. Author manuscript; available in PMC: 2020 Sep 3.
Published in final edited form as: Mol Pharm. 2019 Jul 30;16(9):4017–4023. doi: 10.1021/acs.molpharmaceut.9b00671

Figure 4.

Figure 4.

Cytokine levels in chamber fluids on Day 4: (A) IL-1β; (B) IL-6. Cytokine levels in chamber fluids for negative control and treatments with 37.5 mg/kg HP-PO/NO polymers as a function of time: (C) IL-1β; (D) IL-6. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <0.0001 compared to untreated negative control.